August 2023

My Lab: Specialist Clinical Biochemistry

Associate Practitioner Edna Rodrigues gives a guided tour of her laboratory at North West London Pathology.

Here to help: Professional registration

IBMS Professional Support Services Manager Christian Burt explains the benefits of professional registration and how to apply.

Breastfeeding at work

To mark World Breastfeeding Week (1–7 Aug), Simone Girdham, Biomedical Scientist and member of the IBMS Equity, Diversity and Inclusion (EDI) Group, looks at the issues.

ChatGPT: Implications for training

Dr Jim Taylor, IBMS Head of Digital Education, looks at the latest developments and whether we should embrace ChatGPT.

The future is green

Senior Lecturer and Clinical Lab Sustainability Champion Sheri Scott with the latest on clinical laboratories and sustainability.

Highlighting the IBMS routes to registration

Introducing a new IBMS campaign, which includes videos, flyers, leaflets, posters, web pages and social media posts.

Lessons learned from the pandemic

IBMS Chief Executive David Wells was NHS England’s Head of Pathology when COVID struck. He explains what lessons he learned and how they can help the profession. We then hear from a range of IBMS members and scientists on their biggest lessons and takeaways from the pandemic.

Under the microscope: Medical clowns

This month: Medical clowns

DNA test could broaden access to cervical cancer screening

US bioengineers have demonstrated a low-cost, point-of-care DNA test for HPV infections that could make cervical cancer screening more accessible in low- and middle-income countries where the disease kills more than 300,000 women each year.

Newly discovered genetic defect

In the quest to find the origin of the puzzling symptoms in four children, researchers from St. Anna Children’s Cancer Research Institute (CCRI) and the Medical University of Vienna have discovered a completely new disease, linking disruptions of blood formation, the immune system and inflammation.

Can antidepressants help prevent COVID?

New research from King’s College London has found that community mental health patients who were prescribed antidepressants were significantly less likely to test positive for COVID-19 when admitted to inpatient care.